Selection of an antiarrhythmic drug for a sudden-death-prevention trial
- 30 April 1982
- journal article
- clinical trial
- Published by Elsevier BV in American Heart Journal
- Vol. 103 (4), 737-745
- https://doi.org/10.1016/0002-8703(82)90481-1
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTIONThe Lancet, 1980
- Tocainide therapy for refractory ventricular arrhythmiasAmerican Heart Journal, 1980
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980
- Mexiletine therapy in 15 patients with drug-resistant ventricular tachycardiaThe American Journal of Cardiology, 1980
- Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.Cell Metabolism, 1978
- Suppression of ventricular ectopic depolarizations by tocainide.Cell Metabolism, 1977
- The clinical pharmacokinetics of phenytoinJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Antiarrhythmic effects of a lidocaine congener, tocainide, 2‐amino‐2',6'‐propionoxylidide, in manClinical Pharmacology & Therapeutics, 1976
- Antiarrhythmic Drug Therapy for Sporadic Ventricular Ectopic ArrhythmiasCirculation, 1974
- Long-Term Use of Procaine Amide following Acute Myocardial InfarctionCirculation, 1973